Alison D Parisian (Alison Parisian)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 4

Top Topics

Positive Breast Cancer

Dna Methylation

Endoplasmic Reticulum

Top Venues

Molecular cancer therapeutics

Molecular cancer research : MCR

Genes & development

University of California San Diego (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of California San Diego

United States

PHD :: Biomedical Sciences

California Institute of Technology

United States

BSC :: Biology

Publications

Alison D Parisian, Susanna A Barratt, Leslie Hodges-Gallagher, Fabian E Ortega, Guadalupe Peña, Judevin Sapugay, Brandon Robello, Richard Sun, David Kulp, Gopinath S Palanisamy, David C Myles, Peter J Kushner, Cyrus L Harmon
Palazestrant (OP-1250), A Complete Estrogen Receptor Antagonist, Inhibits Wild-type and Mutant ER-positive Breast Cancer Models as Monotherapy and in Combination. Molecular cancer therapeutics 23 (3) (2024)
Alison D Parisian, Susanna A Barratt, Leslie Hodges-Gallagher, Fabian E Ortega, Guadalupe Peña, Judevin Sapugay, Brandon Robello, Richard Sun, David Kulp, Gopinath S Palanisamy, David C Myles, Peter J Kushner, Cyrus L Harmon
Palazestrant (OP-1250), a Complete Estrogen Receptor Antagonist, Inhibits Wild-type and Mutant ER-positive Breast Cancer Models as Monotherapy and in Combination. Molecular cancer therapeutics (2023)
Alison D Parisian, Tomoyuki Koga, Shunichiro Miki, Pascal D Johann, Marcel Kool, John R Crawford, Frank B Furnari
SMARCB1 loss interacts with neuronal differentiation state to block maturation and impact cell stability. Genes & development 34 (19-20) (2020)
Nathan M Jameson, Jianhui Ma, Jorge Benitez, Alejandro Izurieta, Jee Yun Han, Robert Mendez, Alison D Parisian, Frank Furnari
Intron 1-Mediated Regulation of EGFR Expression in EGFR-Dependent Malignancies Is Mediated by AP-1 and BET Proteins. Molecular cancer research : MCR 17 (11) (2019)